Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 1: technical and …

R Salem, KG Thurston - Journal of vascular and interventional radiology, 2006 - Elsevier
Microsphere and particle technology represent the next-generation agents that have formed
the basis of interventional oncology, an evolving subspecialty of interventional radiology …

The diagnosis and medical management of advanced neuroendocrine tumors

GA Kaltsas, GM Besser, AB Grossman - Endocrine reviews, 2004 - academic.oup.com
Neuroendocrine tumors (NETs) constitute a heterogeneous group of neoplasms that
originate from endocrine glands such as the pituitary, the parathyroids, and the …

[BOOK][B] Handbook of radiotherapy physics: theory and practice

P Mayles, A Nahum, JC Rosenwald - 2007 - taylorfrancis.com
From background physics and biological models to the latest imaging and treatment
modalities, the Handbook of Radiotherapy Physics: Theory and Practice covers all …

ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non …

M Falconi, DK Bartsch, B Eriksson, G Klöppel… - …, 2012 - karger.com
The WHO 2010 classification [1] distinguishes between well-differentiated neuroendocrine
tumors (NETs) and poorly differentiated neuroendocrine carcinomas (NECs) of small or …

[HTML][HTML] Randomised trial of SIR-Spheres® plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer

B Gray, G Van Hazel, M Hope, M Burton, P Moroz… - Annals of …, 2001 - Elsevier
Summary Purpose SIR-Spheres® are radioactive yttrium 90 microspheres (SIR-Spheres®,
Sirtex Medical Limited, Australia) used to selectively target high levels of ionising radiation to …

Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours

S Ho, WY Lau, TWT Leung, M Chan, YK Ngar… - European journal of …, 1996 - Springer
A uniform distribution of yttrium-90 (90 Y) microspheres throughout the entire liver has
always been assumed for dose calculation in treating hepatic tumours. A simple …

ICRP publication 139: occupational radiological protection in interventional procedures

PO López, LT Dauer, R Loose, CJ Martin… - Annals of the …, 2018 - journals.sagepub.com
Over the years, the International Commission on Radiological Protection (ICRP), referred to
below as 'the Commission', has issued recommendations and guidance on protection …

Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience

AS Kennedy, D Coldwell, C Nutting, R Murthy… - International Journal of …, 2006 - Elsevier
Purpose: Salvage therapy for patients with unresectable colorectal liver metastases that
were refractory to oxaliplatin and irinotecan was performed via radioactive microspheres …

Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival

R Salem, RJ Lewandowski, B Atassi, SC Gordon… - Journal of vascular and …, 2005 - Elsevier
PURPOSE: To present safety and efficacy results obtained in treatment of a cohort of
patients with unresectable hepatocellular carcinoma (HCC) with use of 90Y microspheres …

[HTML][HTML] Radioembolization of hepatic lesions from a radiobiology and dosimetric perspective

M Cremonesi, C Chiesa, L Strigari, M Ferrari… - Frontiers in …, 2014 - frontiersin.org
Radioembolization (RE) of liver cancer with 90Y-microspheres has been applied in the last
two decades with notable responses and acceptable toxicity. Two types of microspheres are …